Status:
RECRUITING
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands
Leiden University Medical Center, LUMC, Leiden, The Netherlands
Conditions:
Pulmonary Fibrosis
Interstitial Lung Disease (ILD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on ...
Detailed Description
Patients will be randomly assigned to receive either hospital-based care or a home monitoring program integrated into hospital-based care. Hospital-based care involves outpatient clinic visits every t...
Eligibility Criteria
Inclusion
- A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines;
- Adults (=/\>18 years).
Exclusion
- Patients who are not able to speak, read and/or write in Dutch;
- Patients with no access to the internet;
- Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider;
- Patients who are or have been using a home monitoring program for PF.
Key Trial Info
Start Date :
October 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06883448
Start Date
October 2 2024
End Date
September 1 2026
Last Update
December 22 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pulmonology, Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands
2
Department of Pulmonary Diseases, Rijnstate Hospital
Arnhem, Netherlands
3
Department of Respiratory Medicine, Amphia Hospital
Breda, Netherlands
4
Department of Respiratory Medicine, Catharina Hospital
Eindhoven, Netherlands